CLINICAL_TRIALS trial_result · 2018-08-16

Clinical Trial Update: Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes [Phase 3]

A Phase 3 long-term safety study of MT-2412 in Japanese patients with Type 2 Diabetes Mellitus has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Tanabe Pharma Corporation | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2018-08-16